DEON STANDER - 01 Mar 2024 Form 4 Insider Report for Avery Dennison Corp (AVY)

Role
President & CEO, Director
Signature
/s/ Vikas Arora, attorney-in-fact for Deon Stander
Issuer symbol
AVY
Transactions as of
01 Mar 2024
Net transactions value
+$1,716,016
Form type
4
Filing time
05 Mar 2024, 15:13:41 UTC
Previous filing
05 Sep 2023
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVY Common Stock Options Exercise $422,078 +1,950 +4.2% $216.45 48,428 01 Mar 2024 Direct
transaction AVY Common Stock Tax liability $124,026 -573 -1.2% $216.45 47,855 01 Mar 2024 Direct
transaction AVY Common Stock Options Exercise $175,541 +811 +1.7% $216.45 48,666 01 Mar 2024 Direct
transaction AVY Common Stock Tax liability $51,732 -239 -0.49% $216.45 48,427 01 Mar 2024 Direct
transaction AVY Common Stock Options Exercise $389,826 +1,801 +3.7% $216.45 50,228 01 Mar 2024 Direct
transaction AVY Common Stock Tax liability $119,913 -554 -1.1% $216.45 49,674 01 Mar 2024 Direct
transaction AVY Common Stock Options Exercise $294,156 +1,359 +2.7% $216.45 51,033 01 Mar 2024 Direct
transaction AVY Common Stock Tax liability $142,424 -658 -1.3% $216.45 50,375 01 Mar 2024 Direct
transaction AVY Common Stock Options Exercise $696,536 +3,218 +6.4% $216.45 53,593 01 Mar 2024 Direct
transaction AVY Common Stock Tax liability $337,013 -1,557 -2.9% $216.45 52,036 01 Mar 2024 Direct
transaction AVY Common Stock Options Exercise $993,722 +4,591 +8.8% $216.45 56,627 01 Mar 2024 Direct
transaction AVY Common Stock Tax liability $480,735 -2,221 -3.9% $216.45 54,406 01 Mar 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVY 2024 MSU Award Award $0 +12,705 $0.000000 12,705 01 Mar 2024 Common Stock 12,705 $0.000000 Direct F1
transaction AVY 2024 PU Award Award $0 +14,497 $0.000000 14,497 01 Mar 2024 Common Stock 14,497 $0.000000 Direct F2
transaction AVY 2020 MSU Award Options Exercise $0 -1,950 -100% $0.000000* 0 01 Mar 2024 Common Stock 1,950 $0.000000 Direct F3
transaction AVY 2021 MSU Award Options Exercise $0 -811 -58% $0.000000 578 01 Mar 2024 Common Stock 811 $0.000000 Direct F4
transaction AVY 2022 MSU Award Options Exercise $0 -1,801 -33% $0.000000 3,703 01 Mar 2024 Common Stock 1,801 $0.000000 Direct F5
transaction AVY 2023 MSU Award Options Exercise $0 -1,359 -25% $0.000000 4,091 01 Mar 2024 Common Stock 1,359 $0.000000 Direct F6
transaction AVY 2021 PU Award Options Exercise $0 -3,218 -100% $0.000000* 0 01 Mar 2024 Common Stock 3,218 $0.000000 Direct F7
transaction AVY 2021 Special PU Award Options Exercise $0 -4,591 -100% $0.000000* 0 01 Mar 2024 Common Stock 4,591 $0.000000 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Market-leveraged stock units (MSUs) vest 25% over one-, two-, three- and four-year performance periods, with the number of shares paid on each vesting date based on our absolute total stockholder return. Each MSU represents a contingent right to receive one share of common stock, plus dividend equivalents accrued during the vesting period.
F2 Performance units (PUs) vest, at the end of fiscal year 2026, provided certain performance objectives are met as determined by the Compensation Committee in February 2027. Each PU represents a contingent right to receive one share of common stock.
F3 Shares reflect the vesting of the fourth tranche of MSUs granted in February 2020 at 180% of target based on our absolute total stockholder return in excess of 10% during the 2020-2023 performance period, plus dividend equivalents accrued during the period.
F4 Shares reflect the vesting of the third tranche of MSUs granted in March 2021 at 134% of target based on our absolute total stockholder return in excess of 10% during the 2021-2023 performance period, plus dividend equivalents accrued during the period.
F5 Shares reflect the vesting of the second tranche of MSUs granted in March 2022 at 94% of target based on our absolute total stockholder return during the 2022-2023 performance period, plus dividend equivalents accrued during the period.
F6 Shares reflect the vesting of the first tranche of MSUs granted in March 2023 at 98% of target based on our absolute total stockholder return during the 2023 performance period, plus dividend equivalents accrued during the period.
F7 Shares reflect the vesting of PUs granted in March 2021 at 123% of target, based 75% on the cumulative economic value added of RBIS (now Solutions Group) and 25% on our relative total stockholder return.
F8 Shares reflect the vesting of PUs granted in March 2021 at 183% of target, based 50% on our cumulative economic value added and 50% on our relative total stockholder return.